INCI · — · CIR review pending · used in 4 products
알지닌/라이신폴리펩타이드
ARGININE/LYSINE POLYPEPTIDE
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.